CCM
Consonance Capital Management Portfolio holdings
AUM
$7.28M
This Quarter Return
+17.71%
1 Year Return
-42.86%
3 Year Return
+319.33%
5 Year Return
+899.35%
10 Year Return
–
AUM
$1.55B
AUM Growth
+$1.55B
(+42%)
Cap. Flow
+$335M
Cap. Flow
% of AUM
21.59%
Top 10 Holdings %
Top 10 Hldgs %
61.57%
Holding
33
New
7
Increased
11
Reduced
3
Closed
4
Top Buys
| 1 |
Puma Biotechnology
PBYI
|
$124M |
| 2 |
Karyopharm Therapeutics
KPTI
|
$81M |
| 3 |
NVRO
NEVRO CORP.
NVRO
|
$75.3M |
| 4 |
Exelixis
EXEL
|
$69.1M |
| 5 |
Verastem
VSTM
|
$49.3M |
Top Sells
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$104M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$54.2M |
| 3 |
AMRN
Amarin Corp
AMRN
|
$39.4M |
| 4 |
Dynavax Technologies
DVAX
|
$32.9M |
| 5 |
Corcept Therapeutics
CORT
|
$8.8M |
Sector Composition
| 1 | Healthcare | 99.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPPI
1
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $146M | 9.41% | 6,963,756 +760,400 | +12% | +$15.9M |
|
|
2
Puma Biotechnology
PBYI
$254M
| $124M | 7.97% | +2,089,117 | New | +$124M |
|
3
Pacira BioSciences
PCRX
$1.2B
| $120M | 7.76% | 3,753,834 +1,118,918 | +42% | +$35.9M |
|
4
Travere Therapeutics
TVTX
$1.56B
| $105M | 6.76% | 3,843,371 +150,000 | +4% | +$4.09M |
|
5
Vanda Pharmaceuticals
VNDA
$279M
| $87.8M | 5.66% | 4,609,043 +1,536,768 | +50% | +$29.3M |
|
|
6
Karyopharm Therapeutics
KPTI
$61.7M
| $81M | 5.22% | +4,767,078 | New | +$81M |
|
|
NVRO
7
DELISTED
NEVRO CORP.
NVRO
| $75.3M | 4.86% | +943,070 | New | +$75.3M |
|
8
UroGen Pharma
URGN
$900M
| $74M | 4.77% | 1,487,491 +341,294 | +30% | +$17M |
|
|
9
Corcept Therapeutics
CORT
$7.35B
| $72.8M | 4.69% | 4,628,417 -560,000 | -11% | -$8.8M |
|
|
10
Exelixis
EXEL
$10.1B
| $69.1M | 4.45% | +3,209,200 | New | +$69.1M |
|
11
United Therapeutics
UTHR
$13.8B
| $64.1M | 4.14% | 566,926 | – | – |
|
|
NUVA
12
DELISTED
NuVasive, Inc.
NUVA
| $57.3M | 3.7% | 1,099,523 | – | – |
|
|
GWPH
13
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $50.8M | 3.28% | 364,300 +91,600 | +34% | +$12.8M |
|
|
14
Verastem
VSTM
$569M
| $49.3M | 3.18% | +7,166,666 | New | +$49.3M |
|
15
Pacific Biosciences
PACB
$393M
| $44.6M | 2.88% | 12,576,002 | – | – |
|
|
STML
16
DELISTED
Stemline Therapeutics, Inc.
STML
| $44.1M | 2.84% | 2,747,198 +140,600 | +5% | +$2.26M |
|
|
LMNX
17
DELISTED
Luminex Corp
LMNX
| $42.5M | 2.74% | +1,440,126 | New | +$42.5M |
|
18
uniQure
QURE
$896M
| $39.5M | 2.55% | 1,045,065 | – | – |
|
19
Vericel Corp
VCEL
$1.83B
| $35M | 2.26% | 3,608,092 +503,500 | +16% | +$4.88M |
|
20
Savara
SVRA
$567M
| $30.7M | 1.98% | 2,711,190 | – | – |
|
|
OXFD
21
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $30.2M | 1.94% | 2,339,184 | – | – |
|
22
ADMA Biologics
ADMA
$4.12B
| $19.2M | 1.24% | 4,249,234 +920,000 | +28% | +$4.15M |
|
23
Catalyst Pharmaceutical
CPRX
$2.52B
| $18.9M | 1.22% | 6,044,719 +1,050,000 | +21% | +$3.28M |
|
|
AMRN
24
Amarin Corp
AMRN
$311M
| $15.4M | 0.99% | 4,968,663 -12,761,270 | -72% | -$39.4M |
|
25
Carisma Therapeutics
CARM
$8.98M
| $14.7M | 0.95% | +7,523,296 | New | +$14.7M |
|